Skip to content

Study of Skin tags, as a risk factor for the development of stroke, obesity and diabetes mellitus.

Study Of Occurrence Of Metabolic Syndrome In Patients With Acrochordons

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/042264
Enrollment
200
Registered
2022-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Kamal Aggarwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age >=18 years with one or more acrochordons.

Exclusion criteria

Exclusion criteria: 1. Patients with skin diseases known to be associated with metabolic syndrome such as psoriasis, vitiligo, acanthosis nigricans (AN), lichen planus (LP) and systemic lupus erythematosus (SLE). 2. Patients with history of endocrine diseases like cushing syndrome, acromegaly, pheochromocytoma, hyperthyroidism, glucagonoma. 3. Patients with a history of isotretinoin use in last six months. 4. Patients with family history of diabetes, hypertension and familial hyperlipidemia. 5. Pregnant woman. 6. Patients on drugs that are known to cause hyperglycemia, hypertension and hyperlipidemia. 7. Patients with history of smoking and alcohol use.

Design outcomes

Primary

MeasureTime frame
To study the association between metabolic syndrome and acrochordons.Timepoint: one year

Secondary

MeasureTime frame
To study the correlation of metabolic syndrome with number and size of acrochordons.Timepoint: one year

Countries

India

Contacts

Public ContactDr Varsha Gowda V M

Pt. B.D. Sharma Post Graduate Institute Of Medical Sciences, Rohtak, Haryana, India 124001

drkamalaggarwal@live.in7988658303

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026